| Authors: |
Villacampa G; Statistics Unit, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; SOLTI Cancer Research Group, Barcelona, Spain; Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain., Pascual T; SOLTI Cancer Research Group, Barcelona, Spain; Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain; Cancer Institute and Blood Disorders, Hospital Clínic de Barcelona, Barcelona, Spain., Tarantino P; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Cortés J; Medica Scientia Innovation Research, Barcelona, Spain; International Breast Cancer Center, Pangaea Oncology, Quiron Group, Barcelona, Spain; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain., Perez-García J; Medica Scientia Innovation Research, Barcelona, Spain; International Breast Cancer Center, Pangaea Oncology, Quiron Group, Barcelona, Spain., Llombart-Cussac A; Medica Scientia Innovation Research, Barcelona, Spain; Arnau de Vilanova Hospital, Valencia, Spain., Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Mancino M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Dieci MV; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Waks AG; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Schettini F; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain; Cancer Institute and Blood Disorders, Hospital Clínic de Barcelona, Barcelona, Spain., Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain; Reveal Genomics, Barcelona, Spain., Griguolo G; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., de Castro BA; Department of Medical Oncology, INIBIC, A Coruña University Hospital, A Coruña, Spain., Reboredo C; Department of Medical Oncology, INIBIC, A Coruña University Hospital, A Coruña, Spain., Antolín S; Department of Medical Oncology, INIBIC, A Coruña University Hospital, A Coruña, Spain., Bueno-Muiño C; Hospital Infanta Cristina-Parla, Madrid, Spain., Echavarría I; Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., López-Tarruella S; Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Massarrah T; Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Del Monte-Millán M; Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Martín M; Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Buckingham W; Reveal Genomics, Barcelona, Spain., Parker JS; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Vivancos A; Cancer Genomics Group, VHIO, Barcelona, Spain., Polyak K; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Filho OM; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, MA, USA., Wolff AC; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., DeMichele A; Department of Oncology, University of Pennsylvania, Philadelphia, PA, USA., Tung NM; Beth Israel Deaconess Medical Center, Boston, MA, USA., Perou CM; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Paré L; Reveal Genomics, Barcelona, Spain., Villagrasa P; Reveal Genomics, Barcelona, Spain., Prat A; Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain; Cancer Institute and Blood Disorders, Hospital Clínic de Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain; Institute of Oncology-Quirón, Barcelona, Spain. Electronic address: alprat@clinic.cat., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. |
